These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 16460257)

  • 1. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects.
    Heden G; Wennström JL
    J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results.
    Leknes KN; Andersen KM; Bøe OE; Skavland RJ; Albandar JM
    J Periodontol; 2009 Feb; 80(2):219-27. PubMed ID: 19186961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
    Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
    J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.
    Gamal AY; Mailhot JM
    J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of a regenerative strategy for intrabony defects: scientific evidence and clinical experience.
    Cortellini P; Tonetti MS
    J Periodontol; 2005 Mar; 76(3):341-50. PubMed ID: 15857066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects.
    Trombelli L; Bottega S; Zucchelli G
    J Clin Periodontol; 2002 May; 29(5):433-9. PubMed ID: 12060426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enamel matrix proteins in the treatment of deep intrabony defects.
    Cardaropoli G; Leonhardt AS
    J Periodontol; 2002 May; 73(5):501-4. PubMed ID: 12027251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EDTA gel root conditioning: lack of effect on clinical and radiographic outcomes of intrabony defect treatment with enamel matrix derivative.
    Parashis AO; Tsiklakis K; Tatakis DN
    J Periodontol; 2006 Jan; 77(1):103-10. PubMed ID: 16579710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.
    Sculean A; Windisch P; Chiantella GC; Donos N; Brecx M; Reich E
    J Clin Periodontol; 2001 May; 28(5):397-403. PubMed ID: 11350501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R; Schreiber D; Flores-de-Jacoby L
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
    Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
    Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papilla preservation technique combined with Emdogain in the treatment of intrabony defects: a novel treatment regimen for chronic periodontitis.
    Miliauskaite A; Selimovic D; Hassan M; Nagano F; Soell M; Sano H; Puriene A
    Stomatologija; 2008; 10(1):22-6. PubMed ID: 18493162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
    Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
    J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
    Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
    J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
    Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
    J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
    Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
    Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.